Profile data is unavailable for this security.
About the company
Nyrada Inc. is a preclinical stage, drug development company specializing in small molecule drugs to treat cardiovascular and neurological diseases. The Company’s two lead programs are focused on cholesterol-lowering and brain injury. These programs are developing an oral, small molecule cholesterol-lowering drug, and a drug to reduce secondary brain damage following a stroke or traumatic brain injury (TBI). Its Cholesterol-Lowering Program is an oral PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs. Its Brain Injury Program is developing a drug to block secondary brain damage that occurs following a stroke or TBI, such as severe head trauma from contact sports, a fall, or a motor vehicle accident. The Brain Injury Program is a neuroprotectant drug to reduce the impact of long-term disability in patients who suffer a traumatic brain injury or ischemic stroke. It is also developing new therapies.
- Revenue in AUD (TTM)3.08m
- Net income in AUD-4.98m
- Incorporated2017
- Employees--
- LocationNyrada IncSuite 2, Level 3,, 828 Pacific HighwayGORDON 2072AustraliaAUS
- Phone+61 29053-1990
- Fax+61 29053-1999
- Websitehttps://www.nyrada.com/site/content/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioxyne Ltd | 8.65m | -14.17m | 10.23m | 16.00 | -- | 3.28 | -- | 1.18 | -0.0074 | -0.0074 | 0.0044 | 0.0015 | 1.83 | 6.12 | 10.50 | -- | -302.23 | -22.07 | -418.10 | -28.50 | 38.30 | 45.13 | -165.04 | -39.69 | 1.50 | -- | 0.00 | -- | 1,013.05 | 20.97 | -292.69 | -- | -19.86 | -- |
| TrivarX Ltd | 20.81k | -3.74m | 10.65m | 4.00 | -- | 1.05 | -- | 511.82 | -0.0182 | -0.0182 | 0.00009 | 0.0249 | 0.0023 | -- | -- | -- | -42.02 | -41.56 | -47.15 | -50.51 | 100.00 | 92.74 | -17,949.78 | -334.16 | -- | -147.21 | 0.0072 | -- | -4.69 | -18.06 | 75.85 | -- | -- | -- |
| Althea Group Holdings Ltd | 28.70m | -20.99m | 10.94m | -- | -- | 0.7138 | -- | 0.3813 | -0.059 | -0.059 | 0.0796 | 0.0378 | 0.6181 | 2.47 | 5.53 | -- | -45.22 | -31.09 | -66.73 | -36.32 | 54.64 | 50.76 | -73.15 | -101.39 | 0.4899 | -46.55 | 0.2756 | -- | 22.43 | 335.18 | -13.21 | -- | -- | -- |
| Firebrick Pharma Ltd | 0.00 | -4.57m | 11.72m | -- | -- | 6.72 | -- | -- | -0.0266 | -0.0266 | 0.00 | 0.0089 | 0.00 | -- | -- | -- | -120.70 | -- | -136.04 | -- | -- | -- | -- | -- | 4.37 | -- | 0.00 | -- | -79.85 | -- | -79.18 | -- | -- | -- |
| Radiopharm Theranostics Ltd | 0.00 | -46.82m | 12.43m | -- | -- | 0.414 | -- | -- | -0.1343 | -0.1343 | 0.00 | 0.0652 | 0.00 | -- | -- | -- | -63.11 | -- | -77.85 | -- | -- | -- | -- | -- | -- | -7.48 | 0.00 | -- | -- | -- | -13.78 | -- | -- | -- |
| Avecho Biotechnology Ltd | 473.55k | -3.44m | 12.68m | 29.00 | -- | 1.99 | -- | 26.77 | -0.0016 | -0.0016 | 0.0002 | 0.002 | 0.0888 | 2.07 | 0.5132 | -- | -64.45 | -47.08 | -75.73 | -55.25 | -9.25 | 78.67 | -725.70 | -156.43 | 8.19 | -- | 0.0267 | -- | -58.07 | -19.42 | -46.71 | -- | -- | -- |
| Nyrada Inc | 3.08m | -4.98m | 13.28m | -- | -- | 2.52 | -- | 4.31 | -0.0319 | -0.0319 | 0.0198 | 0.0294 | 0.3983 | -- | -- | -- | -64.37 | -64.90 | -71.93 | -84.66 | -- | -- | -161.62 | -380.62 | -- | -15,086.39 | 0.00 | -- | 42.54 | 229.09 | -96.52 | -- | -- | -- |
| Tissue Repair Ltd | 457.52k | -3.28m | 13.30m | -- | -- | 0.7724 | -- | 29.07 | -0.0542 | -0.0542 | 0.0076 | 0.2848 | 0.0209 | -- | 7.95 | -- | -14.96 | -- | -15.46 | -- | 98.19 | -- | -716.30 | -- | 25.84 | -- | 0.00 | -- | -- | -- | 38.95 | -- | -- | -- |
| Adalta Ltd | 3.56m | -5.04m | 14.44m | -- | -- | 5.86 | -- | 4.05 | -0.0129 | -0.0129 | 0.0092 | 0.0046 | 0.5491 | -- | 4.72 | -- | -77.76 | -67.77 | -195.09 | -103.16 | -- | -- | -141.60 | -160.72 | -- | -57.86 | 0.4533 | -- | 28.18 | 11.17 | 19.96 | -- | -7.47 | -- |
| Medlab Clinical Ltd | 366.64k | -3.94m | 15.07m | 14.00 | -- | -- | -- | 41.11 | -1.73 | -1.73 | 0.1606 | -0.3068 | 0.1069 | -- | 5.82 | -- | -103.72 | -55.07 | -240.52 | -69.75 | 84.77 | 52.86 | -970.74 | -335.43 | -- | -342.19 | -- | -- | -28.90 | -29.83 | 18.55 | -- | -30.00 | -- |
| Argent BioPharma Ltd | 1.32m | -17.02m | 15.85m | -- | -- | 9.42 | -- | 11.97 | -3.32 | -3.32 | 0.1003 | 0.0372 | 0.0813 | 0.7078 | 1.58 | -- | -105.32 | -111.29 | -345.98 | -171.05 | 21.87 | 32.52 | -1,295.20 | -632.42 | 0.6561 | -24.85 | 0.4104 | -- | -28.41 | 47.31 | -2.34 | -- | -16.20 | -- |
| Chimeric Therapeutics Ltd | 0.00 | -11.31m | 16.39m | -- | -- | 0.9948 | -- | -- | -0.027 | -0.027 | 0.00 | 0.0191 | 0.00 | -- | -- | -- | -45.96 | -- | -69.36 | -- | -- | -- | -- | -- | -- | -10.01 | 0.1596 | -- | -- | -- | -60.40 | -- | -- | -- |
| Patrys Ltd | 1.70m | -5.12m | 16.46m | 15.00 | -- | 3.28 | -- | 9.71 | -0.0025 | -0.0025 | 0.0008 | 0.0024 | 0.1978 | -- | 0.5828 | -- | -59.77 | -43.96 | -68.99 | -47.06 | -- | -- | -302.26 | -230.44 | -- | -- | 0.00 | -- | -14.45 | 40.52 | -4.15 | -- | -- | -- |
| BTC Health Ltd | 16.03k | -8.26m | 16.53m | 1.00 | -- | 3.05 | 10.01 | 1,031.21 | -0.0305 | -0.0305 | 0.00005 | 0.0167 | 0.0017 | -- | 0.031 | -- | -89.67 | -23.15 | -91.36 | -24.64 | -- | -- | -51,522.02 | -2,498.18 | -- | -0.0787 | 0.00 | -- | -86.04 | -26.76 | -1,665.01 | -- | -- | -- |
| Oncosil Medical Ltd | 355.30k | -11.71m | 16.66m | 2.00 | -- | 2.56 | -- | 46.89 | -0.0081 | -0.0081 | 0.0002 | 0.002 | 0.0506 | -- | 7.88 | -- | -166.55 | -57.65 | -234.81 | -64.83 | -426.96 | -- | -3,295.08 | -473.02 | -- | -68.93 | 0.0256 | -- | -59.92 | -37.72 | -5.74 | -- | 40.13 | -- |
| Auscann Group Holdings Ltd | 2.05m | -9.44m | 17.61m | 27.00 | -- | -- | -- | 8.60 | -0.0213 | -0.0217 | 0.0043 | 0.0162 | 0.1674 | -- | 5.35 | -- | -77.15 | -39.85 | -78.72 | -40.73 | 100.59 | -- | -460.74 | -925.91 | -- | -23.16 | 0.00 | -- | 13.88 | 51.37 | 57.10 | -- | -- | -- |
